Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Marchex (MCHX) EBT (2016 - 2025)

Marchex (MCHX) has 16 years of EBT data on record, last reported at -$2.4 million in Q4 2025.

  • On a quarterly basis, EBT fell 47.12% to -$2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.2 million, a 12.9% decrease, with the full-year FY2025 number at -$5.2 million, down 12.9% from a year prior.
  • EBT reached -$2.4 million in Q4 2025 per MCHX's latest filing, down from -$993000.0 in the prior quarter.
  • Over the last five years, EBT for MCHX hit a ceiling of $3.3 million in Q3 2021 and a floor of -$5.3 million in Q1 2021.
  • A 5-year average of -$1.5 million and a median of -$1.5 million in 2022 define the central range for EBT.
  • Peak YoY movement for EBT: skyrocketed 157.53% in 2021, then crashed 463.74% in 2022.
  • Tracing MCHX's EBT over 5 years: stood at -$615000.0 in 2021, then plummeted by 463.74% to -$3.5 million in 2022, then soared by 68.21% to -$1.1 million in 2023, then tumbled by 46.73% to -$1.6 million in 2024, then tumbled by 47.12% to -$2.4 million in 2025.
  • Business Quant data shows EBT for MCHX at -$2.4 million in Q4 2025, -$993000.0 in Q3 2025, and $90000.0 in Q2 2025.